The effect of 2-methoxyestradiol liposome on growth inhibition, angiogenesis and expression of VEGF and Ki67 in mice bearing H22 hepatocellular carcinoma

Tumori

Volumn 97, Issue 5, 2011, Pages 660-665

  Du, Bin ^a   Wang, Shu Yu ^a   Shi, Xiu Fang ^a   Zhang, Chao Feng ^a   Zhang, Zhen Zhong ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

2 methoxyestradiol; Liposome; Pharmacodynamics

Indexed keywords

2 METHOXYESTRADIOL; CD31 ANTIGEN; KI 67 ANTIGEN; LIPOSOME; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMATOXYLIN EOSIN STAINING; IMMUNOHISTOCHEMISTRY; LIPOSOMAL DELIVERY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STAINING; TISSUE DISTRIBUTION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 83055193662     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161109700520     Document Type: Article

References (13)

1. Sutherland TE, Anderson RL, Hughes RA, Altmann E, Schuliga M, Ziogas J, Stewart AG: 2-Methoxyestradiol-a unique blend of activities generating a new class of antitumour/ anti-inflammatory agents. Drug Discov Today, 12: 577-584, 2007. (Pubitemid 47031662)
2. Dantas AP, Sandberg K: Does 2-methoxyestradiol represent the new and improved hormone replacement therapy for atherosclerosis? Circ Res, 99: 234-237, 2006. (Pubitemid 44174929)
3. Huerta S, Baay GJ, Garcia R, Hernandez R, Vega MI, Gonzalez C, Bonavida B: 2-Methoxyestradiol reduces the airway inflammation and remodeling in an experimental mouse model. Clin Immun, 129: 313-324, 2008.
4. Batzri S, Korn ED: Single bilayer liposomes prepared without sonication. BiochimBiophys Acta, 298: 1015-1019, 1973.
5. Du B, Li Y, Li XT, A YM, Chen CQ, Zhang ZZ: Preparation, characterization and in vivo evaluation of 2-methoxyestradiol- loaded liposomes. Inter J Pharm, 384: 140-147, 2010.
6. Kunig AM, Balasubramaniam V, Markham NE, Morgan D, Montgomery G, Grover TR, Abman SH: Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats. Am J Physiol Lung Cell Mol Physiol, 289: 529-535, 2005.
7. Ricardo BR, Motta RR, Machado SM, Cambruzzi E, Zettle EW, Zettler CG, Jotz GP: Prognostic value of the immunohistochemistry correlation of Ki-67 and p53 in squamous cell carcinomas of the larynx. Braz J Otorhinolaryngol, 74: 855-859, 2008.
8. Shibusa T, Shijubo N, Abe S: Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. Clin Cancer Res, 4: 1483-1487, 1998. (Pubitemid 28265232)
9. Brahn E, Banquerigo ML, Lee JK, Park EJ, Fogler WE, Plum SM: An angiogenesis inhibitor, 2-methoxyestradiol, involutes rat collagen-induced arthritis and suppresses gene expression of synovial vascular endothelial growth factor and basic fibroblast growth factor. J Rheumatol, 35: 2119- 2128, 2008.
10. Yuan ZP, Chen LJ, Fan LY, Tang MH, Yang GL, Yang HS, Du XB, Wang GQ, Yao WX, Zhao QM, Wang R, Diao P, Zhang W, Wu HB, Zhao X, Wei YQ: Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin Cancer Res, 12: 3193-3199, 2006. (Pubitemid 43837369)
11. Sun W, Zhang N, Li A, Zou W, Xu W: Preparation and evaluation of N3-O-toluyl-fluorouracil-loaded liposomes. Int J Pharm, 353: 243-250, 2007.
12. Liu Z, Wang J, Yin P, Qiu J, Liu R, Li W, Fan X, Cheng X, Chen C, Zhang J, Zhuang G: RGD-fasl induces apoptosis in hepatocellular carcinoma. Cell Mol Immunol, 6: 285-293, 2009.
13. Mooberry SL: New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent. Curr Opin Oncol, 15: 425-430, 2003.